The Autoimmune Disease Diagnosis Market is predicted to reach US$ ~3.95 billion by 2031 from US$ ~9.79 billion in 2020, and to grow at a CAGR of ~8.6% between the forecast period 2021 to 2031.
The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2021 to 2031. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2020. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.
Major segmentation covered in this report is as follows:
Product (Instruments and Consumables & Assay Kits), Type (Localized Autoimmune Disease Diagnostics, Systemic Autoimmune Disease Diagnostics), Test Type (Routine Laboratory Tests, Autoantibodies & Immunologic Test, and Inflammatory Markers)
By Region
North America, Europe, Asia Pacific, and the Rest of the World
Major market players covered in this study are
Thermo Fisher Scientific Inc., Siemens Healthcare Private Limited, Abbott, Trinity Biotech Plc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., bioMérieux SA, Euroimmun Medizinische Labordiagnostika AG (a PerkinElmer company), and Inova Diagnostics, Inc., among others.
1. INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years - 2018 & 2019
2. Base Year - 2020
3. Forecasted Years - 2021 to 2031
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Autoimmune Disease Diagnosis Market - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Autoimmune Disease Diagnosis Market - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Autoimmune Disease Diagnosis Market - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Autoimmune Disease Diagnosis Market - ANALYSIS & FORECAST, BY REGION
North America Autoimmune Disease Diagnosis Market
1. North America Autoimmune Disease Diagnosis Market, by Country
1. US
2. Canada
1. North America Autoimmune Disease Diagnosis Market, by Product
2. North America Autoimmune Disease Diagnosis Market, by Type
3. North America Autoimmune Disease Diagnosis Market, by Gender
4. North America Autoimmune Disease Diagnosis Market, by Sales Channel
3. Europe Autoimmune Disease Diagnosis Market
1. Europe Autoimmune Disease Diagnosis Market, by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Autoimmune Disease Diagnosis Market, by Product
3. Europe Autoimmune Disease Diagnosis Market, by Type
4. Europe Autoimmune Disease Diagnosis Market, by Gender
5. Europe Autoimmune Disease Diagnosis Market, by Sales Channel
4. Asia Pacific Autoimmune Disease Diagnosis Market
1. Asia Pacific Autoimmune Disease Diagnosis Market, by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Autoimmune Disease Diagnosis Market, by product
3. Asia Pacific Autoimmune Disease Diagnosis Market, by Type
4. Asia Pacific Autoimmune Disease Diagnosis Market, by Gender
5. Asia Pacific Autoimmune Disease Diagnosis Market, by Sales Channel
5. Rest of the World Autoimmune Disease Diagnosis Market
1. Rest of the World Autoimmune Disease Diagnosis Market, by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Autoimmune Disease Diagnosis Market, by Product
3. Rest of the World Autoimmune Disease Diagnosis Market, by Type
4. Rest of the World Autoimmune Disease Diagnosis Market, by Gender
5. Rest of the World Autoimmune Disease Diagnosis Market, by Sales Channel
2. COMPANY PROFILES
Company 1, Company 7
The Chronic Kidney Disease Management Technology Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive l...
The Industrial Disease Prevention Systems Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscap...
The Third-party Pathology Diagnosis Center Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsca...
Market Overview
The Asia Pacific Neurofibromatosis Treatment Market is anticipated to witness substantial growth from 2024 to 2034, driven by increasing awareness and diagnosis of neurofibromatosis (NF), advancements in treatment options, and a growing patient population. The market is ...
Market Overview
The Europe Neurofibromatosis Treatment Market is projected to experience substantial growth from 2024 to 2034, driven by advancements in medical treatments, increasing prevalence of neurofibromatosis disorders, and rising awareness about these conditions. The market is e...
Market Overview
The North America Neurofibromatosis Treatment Market is poised for substantial growth from 2024 to 2034, driven by advancements in medical research, increased awareness of neurofibromatosis (NF), and the development of novel therapies. The market size is anticipated to r...
Market Overview
The Global Neurofibromatosis Treatment Market is projected to witness significant growth from 2024 to 2034, driven by advancements in medical research, increasing awareness about neurofibromatosis, and the development of novel therapies. Valued at USD XX.XX billion in 20...
The Chronic Heart Disease Management Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ma...
The Autoimmune Disease Therapies Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufa...
The Digital Platform for Chronic Kidney Disease Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive la...